Takara Bio (Takara Bio) 3-Year Revenue Growth Rate : -1.90% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Takara Bio 3-Year Revenue Growth Rate?

Takara Bio's Revenue per Share for the three months ended in Mar. 2024 was $0.76.

During the past 12 months, Takara Bio's average Revenue per Share Growth Rate was -44.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Takara Bio was 31.20% per year. The lowest was -3.00% per year. And the median was 6.40% per year.

Competitive Comparison of Takara Bio's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Takara Bio's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takara Bio's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Takara Bio's 3-Year Revenue Growth Rate falls into.

Takara Bio 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Takara Bio (OTCPK:TKBIF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Takara Bio 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Takara Bio's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (Takara Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (OTCPK:TKBIF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

4974:Japan TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (Takara Bio) Headlines

No Headlines